688670 金迪克
已收盘 09-14 15:00:01
资讯
新帖
简况
每周股票复盘：金迪克（688670）将召开2026年半年度业绩说明会
证券之星 · 09-13 03:52
每周股票复盘：金迪克（688670）将召开2026年半年度业绩说明会
金迪克（688670）披露2026年半年度业绩说明会公告，9月10日股价下跌0.7%
证券之星 · 09-10
金迪克（688670）披露2026年半年度业绩说明会公告，9月10日股价下跌0.7%
每周股票复盘：金迪克（688670）股东户数降11.18%
证券之星 · 08-23
每周股票复盘：金迪克（688670）股东户数降11.18%
金迪克(688670)6月30日股东户数0.57万户，较上期减少11.18%
证券之星 · 08-21
金迪克(688670)6月30日股东户数0.57万户，较上期减少11.18%
股市必读：金迪克新发布《江苏金迪克生物技术股份有限公司关于控股股东、共同实际控制人续签共同控制暨一致行动协议的公告》
证券之星 · 08-05
股市必读：金迪克新发布《江苏金迪克生物技术股份有限公司关于控股股东、共同实际控制人续签共同控制暨一致行动协议的公告》
金迪克（688670）披露控股股东及共同实际控制人续签一致行动协议公告，8月3日股价上涨3.73%
证券之星 · 08-03
金迪克（688670）披露控股股东及共同实际控制人续签一致行动协议公告，8月3日股价上涨3.73%
金迪克获得实用新型专利授权：“一种禽蛋分选机台的清洗装置”
证券之星 · 07-04
金迪克获得实用新型专利授权：“一种禽蛋分选机台的清洗装置”
股市必读：金迪克（688670）6月18日董秘有最新回复
证券之星 · 06-22
股市必读：金迪克（688670）6月18日董秘有最新回复
金迪克：新建新型四价流感病毒裂解疫苗车间建设项目
证券之星 · 06-18
金迪克：新建新型四价流感病毒裂解疫苗车间建设项目
金迪克：产能悬顶、产品单一，科创板“第五套标准”公司的生存困局
新浪证券 · 06-18
金迪克：产能悬顶、产品单一，科创板“第五套标准”公司的生存困局
股市必读：金迪克（688670）今年截至6月2日累计跌幅已超25%
证券之星 · 06-03
股市必读：金迪克（688670）今年截至6月2日累计跌幅已超25%
股市必读：金迪克（688670）今年截至5月28日累计跌幅已超20%
证券之星 · 05-29
股市必读：金迪克（688670）今年截至5月28日累计跌幅已超20%
每周股票复盘：金迪克（688670）完成董事会换届选举
证券之星 · 05-17
每周股票复盘：金迪克（688670）完成董事会换届选举
金迪克（688670）披露2025年年度股东会决议公告，5月14日股价上涨0.98%
证券之星 · 05-14
金迪克（688670）披露2025年年度股东会决议公告，5月14日股价上涨0.98%
每周股票复盘：金迪克（688670）召开2025年年度股东会
证券之星 · 05-10
每周股票复盘：金迪克（688670）召开2025年年度股东会
每周股票复盘：金迪克（688670）一季度净利降27.34%
证券之星 · 04-26
每周股票复盘：金迪克（688670）一季度净利降27.34%
股市必读：金迪克年报 - 第四季度单季净利润同比下降129.29%
证券之星 · 04-24
股市必读：金迪克年报 - 第四季度单季净利润同比下降129.29%
图解金迪克年报：第四季度单季净利润同比下降129.29%
证券之星 · 04-23
图解金迪克年报：第四季度单季净利润同比下降129.29%
金迪克（688670）披露2025年度利润分配预案，4月22日股价下跌1.38%
证券之星 · 04-22
金迪克（688670）披露2025年度利润分配预案，4月22日股价下跌1.38%
每周股票复盘：金迪克（688670）副总邹镜预因个人原因辞职
证券之星 · 03-22
每周股票复盘：金迪克（688670）副总邹镜预因个人原因辞职
加载更多
公司概况
公司名称：
江苏金迪克生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2021-08-02
主营业务：
江苏金迪克生物技术股份有限公司的主营业务是人用疫苗的研发、生产和销售。公司的主要产品是四价流感病毒裂解疫苗。公司2014年6月至2016年12月独立承担了“新型四价流感病毒裂解疫苗的研制”的“重大新药创制”国家科技重大专项课题，并于2017年12月通过原国家卫计委的课题验收。
发行价格：
55.18
{"stockData":{"symbol":"688670","market":"SH","secType":"STK","nameCN":"金迪克","latestPrice":17.8,"timestamp":1789369201000,"preClose":16.56,"halted":0,"volume":3596472,"delay":0,"changeRate":0.0749,"floatShares":123000000,"shares":123000000,"eps":-1.5413,"marketStatus":"已收盘","change":1.24,"latestTime":"09-14 15:00:01","open":16.9,"high":18.09,"low":16.7,"amount":63000500,"amplitude":0.0839,"askPrice":17.8,"askSize":62,"bidPrice":17.78,"bidSize":47,"shortable":0,"etf":0,"ttmEps":-1.5413,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":5,"adr":0,"adjPreClose":16.56,"symbolType":"stock_kcb","openAndCloseTimeList":[[1789349400000,1789356600000],[1789362000000,1789369200000]],"highLimit":18.22,"lowLimit":14.9,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":123200000,"isCdr":false,"pbRate":2.09,"roa":"--","roe":"--","epsLYR":-1.45,"committee":-0.001504,"marketValue":2193000000,"turnoverRate":0.0292,"status":0,"afterMarket":{"amount":0,"volume":0,"close":17.8,"buyVolume":0,"sellVolume":0,"time":1789371237746,"indexStatus":"已收盘 09-14 15:30:00","preClose":16.56},"floatMarketCap":2193000000},"requestUrl":"/m/hq/s/688670/","defaultTab":"news","newsList":[{"id":"2667050027","title":"每周股票复盘：金迪克（688670）将召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2667050027","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667050027?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:52","pubTimestamp":1789242731,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，金迪克报收于16.56元，较上周的15.97元上涨3.69%。本周，金迪克9月10日盘中最高价报17.55元。本周关注点公司公告汇总：江苏金迪克将于2026年9月17日召开2026年半年度业绩说明会。公司公告汇总江苏金迪克生物技术股份有限公司将于2026年9月17日13:00-14:00通过上海证券交易所“上证路演中心”网络平台召开2026年半年度业绩说明会，介绍公司上半年经营成果、财务状况，并与投资者进行网络文字互动交流。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688670"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666562606","title":"金迪克（688670）披露2026年半年度业绩说明会公告，9月10日股价下跌0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666562606","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666562606?lang=zh_cn&edition=full","pubTime":"2026-09-10 18:12","pubTimestamp":1789035166,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，金迪克报收于17.11元，较前一交易日下跌0.7%，最新总市值为21.08亿元。江苏金迪克生物技术股份有限公司于近日发布《关于召开2026年半年度业绩说明会的公告》。公告显示，公司将于2026年9月17日13:00-14:00通过上海证券交易所“上证路演中心”网络平台召开2026年半年度业绩说明会，介绍公司上半年经营成果、财务状况，并与投资者进行网络文字互动交流。投资者可于2026年9月16日17:00前通过指定邮箱或上证路演中心预提交问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000034748.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688670"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661921457","title":"每周股票复盘：金迪克（688670）股东户数降11.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661921457","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661921457?lang=zh_cn&edition=full","pubTime":"2026-08-23 03:46","pubTimestamp":1787427972,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，金迪克报收于15.95元，较上周的16.01元下跌0.37%。本周，金迪克8月20日盘中最高价报18.38元。股本股东变化股东户数变动截至2026年6月30日，公司股东户数为5680.0户，较3月31日减少715.0户，减幅为11.18%。江苏金迪克生物技术股份有限公司2026年半年度报告摘要公司代码688670，股票简称金迪克。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688670"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661269252","title":"金迪克(688670)6月30日股东户数0.57万户，较上期减少11.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661269252","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661269252?lang=zh_cn&edition=full","pubTime":"2026-08-21 17:40","pubTimestamp":1787305227,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金迪克披露，截至2026年6月30日公司股东户数为5680.0户，较3月31日减少715.0户，减幅为11.18%。在生物制品行业个股中，金迪克股东户数低于行业平均水平，截至6月30日，生物制品行业平均股东户数为3.53万户。从股价来看，2026年3月31日至2026年6月30日，金迪克区间跌幅为1.05%，在此期间股东户数减少715.0户，减幅为11.18%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100032344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688670","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657566890","title":"股市必读：金迪克新发布《江苏金迪克生物技术股份有限公司关于控股股东、共同实际控制人续签共同控制暨一致行动协议的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657566890","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657566890?lang=zh_cn&edition=full","pubTime":"2026-08-05 03:23","pubTimestamp":1785871433,"startTime":"0","endTime":"0","summary":"当日关注点交易信息汇总：8月4日主力资金净流入4.81万元，占总成交额0.26%。公司公告汇总：控股股东余军、张良斌于8月1日续签为期12个月的一致行动协议，明确以余军意见为对外一致意见，维持控制权稳定。协议约定双方在董事会、股东会提案权、表决权及董事候选人提名权等方面保持一致行动；无法达成一致时，以余军意见为对外一致意见。本次续签不导致公司控股股东及实际控制人变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500003900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688670","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656370332","title":"金迪克（688670）披露控股股东及共同实际控制人续签一致行动协议公告，8月3日股价上涨3.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656370332","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656370332?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:53","pubTimestamp":1785768791,"startTime":"0","endTime":"0","summary":"公告显示，公司控股股东、共同实际控制人余军先生、张良斌先生于2026年8月1日续签《关于江苏金迪克生物技术股份有限公司共同控制暨一致行动协议》，有效期为12个月，自2026年8月2日起至2027年8月1日止。协议约定双方在公司董事会、股东会的提案权、表决权、董事候选人提名权等方面保持一致行动，如无法达成一致意见，则以余军的意见作为共同实际控制人的对外一致意见。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037924.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688670"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648660675","title":"金迪克获得实用新型专利授权：“一种禽蛋分选机台的清洗装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2648660675","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648660675?lang=zh_cn&edition=full","pubTime":"2026-07-04 03:41","pubTimestamp":1783107712,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示金迪克新获得一项实用新型专利授权，专利名为“一种禽蛋分选机台的清洗装置”，专利申请号为CN202521080297.7，授权日为2026年6月19日。今年以来金迪克新获得专利授权3个，较去年同期增加了200%。通过天眼查大数据分析，江苏金迪克生物技术股份有限公司共对外投资了1家企业，参与招投标项目389次；财产线索方面有商标信息21条，专利信息39条；此外企业还拥有行政许可48个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070400002279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688670"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645161960","title":"股市必读：金迪克（688670）6月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2645161960","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645161960?lang=zh_cn&edition=full","pubTime":"2026-06-22 04:51","pubTimestamp":1782075070,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，金迪克报收于14.28元，下跌0.63%，换手率1.3%，成交量1.6万手，成交额2286.36万元。董秘最新回复投资者： 您好，贵司年报显示2025年营收1.13亿，应收账款却达1.4亿，经营现金流净流出1.66亿，营收质量是否堪忧？请问：1.应收账款回款是否存在重大风险，信用政策是否放宽？当日关注点交易信息汇总：6月18日主力资金净流出192.76万元，占总成交额0.0%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200001644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688670"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644570541","title":"金迪克：新建新型四价流感病毒裂解疫苗车间建设项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2644570541","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644570541?lang=zh_cn&edition=full","pubTime":"2026-06-18 16:24","pubTimestamp":1781771085,"startTime":"0","endTime":"0","summary":"公司的客户主要为各地疾控中心，疾控中心为国家事业单位，其资金来源主要为财政拨款，信用风险低，履约能力强，且主要集中在一年以内，公司应收账款整体信用风险较低，信用政策较往年未发生重大变化；公司业绩情况敬请关注定期报告；公司主要在建工程为“新建新型四价流感病毒裂解疫苗车间建设项目”，该项目已完成土建施工、机器设施设备安装与调试验证、原液与制剂的工艺验证和稳定性研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800028366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159646","688670"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644774680","title":"金迪克：产能悬顶、产品单一，科创板“第五套标准”公司的生存困局","url":"https://stock-news.laohu8.com/highlight/detail?id=2644774680","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644774680?lang=zh_cn&edition=full","pubTime":"2026-06-18 13:00","pubTimestamp":1781758800,"startTime":"0","endTime":"0","summary":"作为科创板少数采用第五套上市标准的生物医药企业，金迪克正面临从经营到合规的多重考验。2025年年报及后续问询回复显示，这家以一款成人型四价流感疫苗撑起全部营收的公司，不仅连续三年亏损，且核心募投产能项目再度延期，实际产销量与规划产能间存在巨大裂口。 金迪克的案例，折射出部分第五套标准上市生物医药公司的共性困境——用资本市场的资金垒起产能高塔，却始终等不来与之匹配的市场需求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-06-18/doc-inicuyvx5583803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688670","BK0239","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640292369","title":"股市必读：金迪克（688670）今年截至6月2日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640292369","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640292369?lang=zh_cn&edition=full","pubTime":"2026-06-03 03:54","pubTimestamp":1780430055,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，金迪克报收于16.26元，下跌4.07%，换手率1.21%，成交量1.49万手，成交额2452.93万元。交易信息汇总股价提醒6月2日金迪克收盘报16.26元，跌4.07%，当日成交2452.93万元。根据收盘数据统计，该股已连续6日下跌，当年累计跌幅28.41%。资金流向6月2日主力资金净流出104.91万元，占总成交额4.28%；游资资金净流入65.74万元，占总成交额2.68%；散户资金净流入39.17万元，占总成交额1.6%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300006164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688670","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639861305","title":"股市必读：金迪克（688670）今年截至5月28日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639861305","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639861305?lang=zh_cn&edition=full","pubTime":"2026-05-29 03:25","pubTimestamp":1779996310,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘，金迪克报收于17.11元，下跌1.21%，换手率1.22%，成交量1.5万手，成交额2553.79万元。当日关注点来自交易信息汇总：金迪克股价连续4日下跌，2026年累计跌幅达22.94%。交易信息汇总股价提醒5月28日金迪克收盘报17.11元，跌1.21%，当日成交149.76万元。资金流向5月28日主力资金净流出106.49万元，占总成交额4.17%；游资资金净流出24.67万元，占总成交额0.97%；散户资金净流入131.16万元，占总成交额5.14%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900004724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688670","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636642980","title":"每周股票复盘：金迪克（688670）完成董事会换届选举","url":"https://stock-news.laohu8.com/highlight/detail?id=2636642980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636642980?lang=zh_cn&edition=full","pubTime":"2026-05-17 03:40","pubTimestamp":1778960422,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，金迪克报收于19.52元，较上周的18.73元上涨4.22%。本周关注点来自公司公告汇总：金迪克于2026年5月14日完成第三届董事会换届选举，余军当选董事长。出席会议股东共31人，代表有表决权股份总数的74.6339%，审议通过2025年度董事会工作报告、年度报告、利润分配预案、续聘会计师事务所、董事薪酬方案及董事会换届选举等议案。部分原董事及高管因任期届满或个人原因离任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001136.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688670","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635457507","title":"金迪克（688670）披露2025年年度股东会决议公告，5月14日股价上涨0.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635457507","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635457507?lang=zh_cn&edition=full","pubTime":"2026-05-14 22:29","pubTimestamp":1778768952,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，金迪克报收于19.57元，较前一交易日上涨0.98%，最新总市值为24.11亿元。该股当日开盘19.36元，最高20.2元，最低18.75元，成交额达7161.6万元，换手率为2.99%。近日，江苏金迪克生物技术股份有限公司发布《2025年年度股东会决议公告》。各项议案均获有效通过，无被否决议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400043088.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688670"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634412460","title":"每周股票复盘：金迪克（688670）召开2025年年度股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2634412460","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634412460?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:40","pubTimestamp":1778355623,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，金迪克报收于18.73元，较上周的17.92元上涨4.52%。本周，金迪克5月8日盘中最高价报18.82元。本周关注点公司公告汇总：江苏金迪克召开2025年年度股东会，审议董事会工作报告、年度报告及利润分配预案等多项议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688670"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630800875","title":"每周股票复盘：金迪克（688670）一季度净利降27.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630800875","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630800875?lang=zh_cn&edition=full","pubTime":"2026-04-26 06:42","pubTimestamp":1777156935,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，金迪克报收于16.99元，较上周的17.65元下跌3.74%。本周，金迪克4月20日盘中最高价报17.83元。公司公告汇总：公司2025年度净利润为负，拟不进行利润分配。业绩披露要点金迪克2026年一季报显示，公司主营收入89.88万元，同比下降74.05%；归母净利润-2238.73万元，同比下降27.34%；扣非净利润-2318.02万元，同比下降17.95%；负债率20.59%，投资收益111.33万元，财务费用53.48万元，毛利率-81.81%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600004168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688670"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629386898","title":"股市必读：金迪克年报 - 第四季度单季净利润同比下降129.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629386898","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629386898?lang=zh_cn&edition=full","pubTime":"2026-04-24 04:09","pubTimestamp":1776974985,"startTime":"0","endTime":"0","summary":"截至2026年4月23日收盘，金迪克报收于16.87元，下跌1.58%，换手率1.25%，成交量1.54万手，成交额2611.71万元。来自业绩披露要点：2025年公司主营收入同比增长39.7%，但归母净利润亏损达1.78亿元，同比下滑90.7%。股本股东变化股东户数变动近日金迪克披露，截至2026年3月31日公司股东户数为6395.0户，较12月31日减少555.0户，减幅为7.99%。该预案尚需提交公司2025年年度股东会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400012421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688670"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629702994","title":"图解金迪克年报：第四季度单季净利润同比下降129.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629702994","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629702994?lang=zh_cn&edition=full","pubTime":"2026-04-23 01:09","pubTimestamp":1776877783,"startTime":"0","endTime":"0","summary":"证券之星消息，金迪克2025年年报显示，当年度公司主营收入1.13亿元，同比上升39.7%；归母净利润-1.78亿元，同比下降90.7%；扣非净利润-1.84亿元，同比下降73.16%；其中2025年第四季度，公司单季度主营收入3822.54万元，同比下降8.78%；单季度归母净利润-9199.42万元，同比下降129.29%；单季度扣非净利润-9296.13万元，同比下降107.63%；负债率22.52%，投资收益641.5万元，财务费用92.01万元，毛利率64.37%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300002292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688670"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629040115","title":"金迪克（688670）披露2025年度利润分配预案，4月22日股价下跌1.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629040115","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629040115?lang=zh_cn&edition=full","pubTime":"2026-04-22 22:33","pubTimestamp":1776868387,"startTime":"0","endTime":"0","summary":"截至2026年4月22日收盘，金迪克报收于17.14元，较前一交易日下跌1.38%，最新总市值为21.12亿元。该股当日开盘17.27元，最高17.45元，最低17.04元，成交额达1742.47万元，换手率为0.82%。近日，江苏金迪克生物技术股份有限公司发布《关于2025年度利润分配预案的公告》。该预案尚需提交公司2025年年度股东会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200055170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688670","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621791586","title":"每周股票复盘：金迪克（688670）副总邹镜预因个人原因辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2621791586","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2621791586?lang=zh_cn&edition=full","pubTime":"2026-03-22 03:30","pubTimestamp":1774121432,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，金迪克报收于17.35元，较上周的18.58元下跌6.62%。本周，金迪克3月16日盘中最高价报18.9元。公司公告汇总江苏金迪克生物技术股份有限公司董事会于2026年3月21日收到副总经理邹镜预先生的辞职报告，邹镜预先生因个人原因申请辞去副总经理职务，辞职后不再担任公司任何职务。其辞职报告自送达董事会之日起生效，原定任期至2026年5月10日。邹镜预先生已完成工作交接，其辞职不会对公司的生产经营造成不利影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200001344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688670"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789378520231,"stockEarnings":[{"period":"1week","weight":0.0369},{"period":"1month","weight":0.0508},{"period":"3month","weight":0.0916},{"period":"6month","weight":-0.1087},{"period":"1year","weight":0.0363},{"period":"ytd","weight":-0.1814}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏金迪克生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"5680人(较上一季度减少11.18%)","perCapita":"21690股","listingDate":"2021-08-02","address":"江苏省泰州市海陵区郁金路12号","registeredCapital":"12320万元","survey":" 江苏金迪克生物技术股份有限公司的主营业务是人用疫苗的研发、生产和销售。公司的主要产品是四价流感病毒裂解疫苗。公司2014年6月至2016年12月独立承担了“新型四价流感病毒裂解疫苗的研制”的“重大新药创制”国家科技重大专项课题，并于2017年12月通过原国家卫计委的课题验收。","listedPrice":55.18},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金迪克(688670)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金迪克(688670)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金迪克,688670,金迪克股票,金迪克股票老虎,金迪克股票老虎国际,金迪克行情,金迪克股票行情,金迪克股价,金迪克股市,金迪克股票价格,金迪克股票交易,金迪克股票购买,金迪克股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金迪克(688670)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金迪克(688670)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}